Antiretroviral therapy at a district hospital in Ethiopia prevents death and tuberculosis in a cohort of HIV patients.

Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.

Predictors of early death in a cohort of Ethiopian patients treated with HAART.

Disease progression among untreated HIV-infected patients in South Ethiopia: implications for patient care.

Incidence of Tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America.

Universal decline in mortality in patients with advanced HIV-1 disease in various demographic subpopulations after the introduction of HAART in Hong Kong, from 1993 to 2002.

Incidence of opportunistic and other infections in HIV-infected children in the HAART era.

Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa.

Impact of antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience, 1995-2001.

Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.

Tuberculosis after HAART initiation in HIV-positive patients from five countries with a high tuberculosis burden.

Trends of mortality and causes of death among HIV-infected patients in Taiwan, 1984-2005.

Effect of routine isoniazid preventive therapy on tuberculosis incidence among HIV-infected men in South Africa: a novel randomized incremental recruitment study.

Comparison of clinical response to initial highly active antiretroviral therapy in the patients in clinical care in the United States and Brazil.

Antiretroviral treatment for children.

Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.

Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study.

Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes.

Risk of recurrent nontyphoid Salmonella bacteremia in HIV-infected patients in the era of highly active antiretroviral therapy and an increasing trend of fluoroquinolone resistance.

HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis.